229 related articles for article (PubMed ID: 23001085)
1. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression.
Schneeberger S; Gorantla VS; Brandacher G; Zeevi A; Demetris AJ; Lunz JG; Metes DM; Donnenberg AD; Shores JT; Dimartini AF; Kiss JE; Imbriglia JE; Azari K; Goitz RJ; Manders EK; Nguyen VT; Cooney DS; Wachtman GS; Keith JD; Fletcher DR; Macedo C; Planinsic R; Losee JE; Shapiro R; Starzl TE; Lee WP
Ann Surg; 2013 Feb; 257(2):345-51. PubMed ID: 23001085
[TBL] [Abstract][Full Text] [Related]
2. From Auto- to Allotransplantation: Immunomodulatory Protocol for Hand and Arm Transplantation.
Lee WPA; Shores JT; Brandacher G
J Reconstr Microsurg; 2018 Nov; 34(9):683-684. PubMed ID: 29775981
[TBL] [Abstract][Full Text] [Related]
3. Favoring the risk-benefit balance for upper extremity transplantation--the Pittsburgh Protocol.
Gorantla VS; Brandacher G; Schneeberger S; Zheng XX; Donnenberg AD; Losee JE; Lee WP
Hand Clin; 2011 Nov; 27(4):511-20, ix-x. PubMed ID: 22051391
[TBL] [Abstract][Full Text] [Related]
4. Experimental short-term immunosuppression after bowel transplantation and donor-specific bone marrow infusion.
Harmon JV; Gruessner AC; Nakhleh RE; Zhang K; Gruessner RW
Arch Surg; 2001 Jul; 136(7):817-21. PubMed ID: 11448397
[TBL] [Abstract][Full Text] [Related]
5. Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China.
Yuan-Xin L; Ning L; You-Sheng L; Xiao-Dong N; Ming L; Jian W; Jie-Shou L
Transplant Proc; 2010; 42(1):29-34. PubMed ID: 20172275
[TBL] [Abstract][Full Text] [Related]
6. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
[TBL] [Abstract][Full Text] [Related]
7. Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine.
Wachtman GS; Wimmers EG; Gorantla VS; Lin CH; Schneeberger S; Unadkat JV; Zheng XX; Brandacher G; Lee WP
Transplant Proc; 2011 Nov; 43(9):3541-4. PubMed ID: 22099837
[TBL] [Abstract][Full Text] [Related]
8. [Musculosceletal reconstruction in bilateral forearm transplantation].
Gabl M; Blauth M; Lutz M; Zimmermann R; Angermann P; Arora R; Piza-Katzer H; Hussl H; Ninkovic M; Ninkovic M; Schneeberger S; Margreiter R
Handchir Mikrochir Plast Chir; 2009 Aug; 41(4):224-9. PubMed ID: 19688653
[TBL] [Abstract][Full Text] [Related]
9. Inducing Transient Mixed Chimerism for Allograft Survival Without Maintenance Immunosuppression With Combined Kidney and Bone Marrow Transplantation: Protocol Optimization.
Lee KW; Park JB; Park H; Kwon Y; Lee JS; Kim KS; Chung YJ; Rhu JS; Choi S; Kwon GY; Kim HJ; Kang ES; Jung CW; Shin EC; Kawai T; Kim SJ; Joh JW
Transplantation; 2020 Jul; 104(7):1472-1482. PubMed ID: 31634324
[TBL] [Abstract][Full Text] [Related]
10. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
Olson KA; West K; McCarthy PL
Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
[TBL] [Abstract][Full Text] [Related]
11. Human hand allograft: report on first 6 months.
Dubernard JM; Owen E; Herzberg G; Lanzetta M; Martin X; Kapila H; Dawahra M; Hakim NS
Lancet; 1999 Apr; 353(9161):1315-20. PubMed ID: 10218530
[TBL] [Abstract][Full Text] [Related]
12. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
Shapiro R; Jordan ML; Basu A; Scantlebury V; Potdar S; Tan HP; Gray EA; Randhawa PS; Murase N; Zeevi A; Demetris AJ; Woodward J; Marcos A; Fung JJ; Starzl TE
Ann Surg; 2003 Oct; 238(4):520-5; discussion 525-7. PubMed ID: 14530723
[TBL] [Abstract][Full Text] [Related]
13. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ
Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring.
Ciancio G; Burke GW; Gaynor JJ; Carreno MR; Cirocco RE; Mathew JM; Mattiazzi A; Cordovilla T; Roth D; Kupin W; Rosen A; Esquenazi V; Tzakis AG; Miller J
Transplantation; 2005 Aug; 80(4):457-65. PubMed ID: 16123718
[TBL] [Abstract][Full Text] [Related]
15. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.
Garcia-Morales R; Carreno M; Mathew J; Zucker K; Cirocco R; Ciancio G; Burke G; Roth D; Temple D; Rosen A; Fuller L; Esquenazi V; Karatzas T; Ricordi C; Tzakis A; Miller J
J Clin Invest; 1997 Mar; 99(5):1118-29. PubMed ID: 9062371
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
[TBL] [Abstract][Full Text] [Related]
17. Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation.
Tzakis AG; Tryphonopoulos P; Kato T; Nishida S; Levi DM; Madariaga JR; Gaynor JJ; De Faria W; Regev A; Esquenazi V; Weppler D; Ruiz P; Miller J
Transplantation; 2004 Apr; 77(8):1209-14. PubMed ID: 15114087
[TBL] [Abstract][Full Text] [Related]
18. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial.
Roemhild A; Otto NM; Moll G; Abou-El-Enein M; Kaiser D; Bold G; Schachtner T; Choi M; Oellinger R; Landwehr-Kenzel S; Juerchott K; Sawitzki B; Giesler C; Sefrin A; Beier C; Wagner DL; Schlickeiser S; Streitz M; Schmueck-Henneresse M; Amini L; Stervbo U; Babel N; Volk HD; Reinke P
BMJ; 2020 Oct; 371():m3734. PubMed ID: 33087345
[TBL] [Abstract][Full Text] [Related]
20. Bone infarction of the hip after hand allotransplantation: A case report.
Kuo YR; Chen CC; Wang JW; Chang JK; Huang YC; Pan CC; Lin YC; Wu RW; Lee CH
Microsurgery; 2019 May; 39(4):349-353. PubMed ID: 30481394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
